microdosing glp 1 Is GLP-1 for weight loss safe and effective? GLP-1 microdosing is experimental and

In the STEP clinical trials, patients using semaglutide achieved average weight loss of 15-22% of their body weight over 68 weeks, with some losing more than 35 pounds

Naunyn-Schmiedebergs Arch Pharmacol 385:953959

Certain underlying conditionssuch as polycystic ovary syndrome (PCOS), which often drives both weight gain and hormonal imbalancemay require extra monitoring when combining these therapies

The American Diabetes Associations position that metformin should remain the first-line treatment for most type 2 diabetes cases is partly driven by this cost advantage at roughly $120 per year versus over $11,000 annually for Rybelsus, metformins modest efficacy is justified for 90% of people starting type 2 diabetes treatment